Heart risks of glucose-lowering drugs being overlooked in clinical trials

[Northerner]

Hospitalization for heart failure is one of the most common and prognostically important complications of diabetes, a new review indicates. Moreover, increasing evidence shows that some glucose-lowering drugs increase the risk of heart failure. Yet, heart failure is rarely considered as a key outcome, or even part of composite cardiovascular outcomes, in clinical trials of glucose-lowering drugs.

http://www.sciencedaily.com/releases/2014/03/140313092422.htm